{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:41:34Z","timestamp":1784234494642,"version":"3.55.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>IL-21 is a multifunctional cytokine linked with the pathophysiology of several autoimmune diseases, including type 1 diabetes. In this study, our aim was to examine plasma IL-21 levels in individuals at different stages of type 1 diabetes progression. We measured plasma IL-21 levels, as well as levels of other key pro-inflammatory cytokines (IL-17A, TNF-\u03b1 and IL-6), from 37 adults with established type 1 diabetes and 46 healthy age-matched adult controls, as well as from 53 children with newly diagnosed type 1 diabetes, 48 at-risk children positive for type 1 diabetes-associated autoantibodies and 123 healthy age-matched pediatric controls using the ultrasensitive Quanterix SiMoA technology. Adults with established type 1 diabetes had higher plasma IL-21 levels compared to healthy controls. However, the plasma IL-21 levels showed no statistically significant correlation with clinical variables, such as BMI, C-peptide, HbA1c, or hsCRP levels, evaluated in parallel. In children, plasma IL-21 levels were almost ten times higher than in adults. However, no significant differences in plasma IL-21 levels were detected between healthy children, autoantibody-positive at-risk children, and children with newly diagnosed type 1 diabetes. In conclusion, plasma IL-21 levels in adults with established type 1 diabetes were increased, which may be associated with autoimmunity. The physiologically high plasma IL-21 levels in children may, however, reduce the potential of IL-21 as a biomarker for autoimmunity in pediatric subjects.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1157265","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T10:04:40Z","timestamp":1687341880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression"],"prefix":"10.3389","volume":"14","author":[{"given":"Anna-Mari","family":"Schroderus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Poorbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"McElyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsti","family":"N\u00e4nt\u00f6-Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"Rintam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Pihlajam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Ilonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Benschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuure","family":"Kinnunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA - J Am Med Assoc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0882","article-title":"Interleukin-21 is required for the development of type 1 diabetes in nod mice","volume":"58","author":"Sutherland","year":"2009","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1172\/JCI76238","article-title":"Follicular helper T cell signature in type 1 diabetes","volume":"125","author":"Kenefeck","year":"2015","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3509-8","article-title":"IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients","volume":"58","author":"Ferreira","year":"2015","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/db16-0714","article-title":"Circulating CXCR5 + PD-1 + ICOS + follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies","volume":"66","author":"Viisanen","year":"2017","journal-title":"Diabetes"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives b cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01924","article-title":"T Cells that help b cells in chronically inflamed tissues","volume":"9","author":"Rao","year":"2018","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1157","article-title":"Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models","volume":"60","author":"McGuire","year":"2011","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.01.021","article-title":"A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity","volume":"34","author":"McGuire","year":"2011","journal-title":"Immunity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201730","article-title":"IL-21 promotes CD8+ CTL activity via the transcription factor T-bet","volume":"190","author":"Sutherland","year":"2013","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4936-8","article-title":"Circulating CXCR5-PD-1hi peripheral T helper cells are associated with progression to type 1 diabetes","volume":"62","author":"Ekman","year":"2019","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000788","article-title":"IL-17 immunity in human type 1 diabetes","volume":"185","author":"Honkanen","year":"2010","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0090","article-title":"Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes","volume":"60","author":"Ferraro","year":"2011","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00019-X","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"von Herrath","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/ar3504","article-title":"Impact of interleukin-21 in the pathogenesis of primary sj\u00f6gren\u2019s syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands","volume":"13","author":"Kang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131025","article-title":"Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ b cells in patients with new-onset systemic lupus erythematosus","volume":"41","author":"Wang","year":"2014","journal-title":"J Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jim.2018.12.005","article-title":"Measurement of IL-21 in human serum and plasma using ultrasensitive MSD s-PLEX\u00ae and quanterix SiMoA methodologies","volume":"466","author":"Poorbaugh","year":"2019","journal-title":"J Immunol Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0142976","article-title":"Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes","volume":"10","author":"Alnek","year":"2015","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079858","article-title":"Inhibition of increased circulating tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes","volume":"8","author":"Xu","year":"2013","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0264","article-title":"Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile","volume":"61","author":"Yeung","year":"2012","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1305","article-title":"Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population","volume":"58","author":"Siljander","year":"2009","journal-title":"Diabetes"},{"key":"B25","unstructured":"Vienna, AustriaR Foundation for Statistical ComputingR: a language and environment for statistical computing2021"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00019","article-title":"FOXP3+ regulatory T cell compartment is altered in children with newly diagnosed type 1 diabetes but not in autoantibody-positive at-risk children","volume":"10","author":"Viisanen","year":"2019","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1157265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T10:04:44Z","timestamp":1687341884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1157265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2023.1157265"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1157265","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"article-number":"1157265"}}